MESA LABORATORIES INC (MLAB) Stock Overview
NASDAQ:MLAB - US59064R1095 - Common Stock
MLAB Key Statistics, Chart & Performance
The current stock price of MLAB is 69.33 USD. In the past month the price decreased by -9.7%. In the past year, price decreased by -48.14%.
MLAB Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 22.32 | 184.45B | ||
| DHR | DANAHER CORP | 27.39 | 147.69B | ||
| A | AGILENT TECHNOLOGIES INC | 21.91 | 33.60B | ||
| IQV | IQVIA HOLDINGS INC | 16.37 | 31.92B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 31.41 | 26.47B | ||
| WAT | WATERS CORP | 24.21 | 17.63B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 35.13 | 17.58B | ||
| ILMN | ILLUMINA INC | 23.73 | 15.17B | ||
| ICLR | ICON PLC | 12.98 | 13.36B | ||
| TEM | TEMPUS AI INC | N/A | 13.26B | ||
| MEDP | MEDPACE HOLDINGS INC | 34.89 | 13.18B | ||
| RVTY | REVVITY INC | 18.66 | 10.59B |
Related stock screener links
About MLAB
Company Profile
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 736 full-time employees. Its segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. The company also provides testing and laboratory services, mainly to the dental and pharmaceutical industries. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services quality control products. The company has manufacturing operations in the United States and Europe.
Company Info
MESA LABORATORIES INC
12100 W 6th Ave
Lakewood COLORADO 80228 US
CEO: Gary M. Owens
Employees: 736
Phone: 13039878000
MESA LABORATORIES INC / MLAB FAQ
What is the stock price of MESA LABORATORIES INC today?
The current stock price of MLAB is 69.33 USD. The price decreased by -3.79% in the last trading session.
What is the ticker symbol for MESA LABORATORIES INC stock?
The exchange symbol of MESA LABORATORIES INC is MLAB and it is listed on the Nasdaq exchange.
On which exchange is MLAB stock listed?
MLAB stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for MESA LABORATORIES INC stock?
8 analysts have analysed MLAB and the average price target is 90.27 USD. This implies a price increase of 30.2% is expected in the next year compared to the current price of 69.33. Check the MESA LABORATORIES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MESA LABORATORIES INC worth?
MESA LABORATORIES INC (MLAB) has a market capitalization of 381.31M USD. This makes MLAB a Small Cap stock.
How many employees does MESA LABORATORIES INC have?
MESA LABORATORIES INC (MLAB) currently has 736 employees.
What are the support and resistance levels for MESA LABORATORIES INC (MLAB) stock?
MESA LABORATORIES INC (MLAB) has a support level at 69.28 and a resistance level at 72.96. Check the full technical report for a detailed analysis of MLAB support and resistance levels.
Is MESA LABORATORIES INC (MLAB) expected to grow?
The Revenue of MESA LABORATORIES INC (MLAB) is expected to grow by 3.51% in the next year. Check the estimates tab for more information on the MLAB EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy MESA LABORATORIES INC (MLAB) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MLAB, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MLAB, evaluating the profitability, health, valuation and growth aspects
- MESA LABORATORIES INC (MLAB) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MESA LABORATORIES INC (MLAB) Sales and EPS estimates to see what analysts future expectations are.
- MESA LABORATORIES INC (MLAB) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MESA LABORATORIES INC (MLAB) Insider and Institutional Ownership to learn about the owners and their transactions.
- MESA LABORATORIES INC (MLAB) Stock Chart to make your own analysis
- MESA LABORATORIES INC (MLAB) Latest news and press-releases to stay up to date.
Does MESA LABORATORIES INC (MLAB) stock pay dividends?
MESA LABORATORIES INC (MLAB) has a dividend yield of 0.96%. The yearly dividend amount is currently 0.64. Check the full fundamental report for a detailed analysis of MLAB dividend history, reliability and sustainability.
When does MESA LABORATORIES INC (MLAB) report earnings?
MESA LABORATORIES INC (MLAB) will report earnings on 2025-11-05.
What is the Price/Earnings (PE) ratio of MESA LABORATORIES INC (MLAB)?
The PE ratio for MESA LABORATORIES INC (MLAB) is 866.63. This is based on the reported non-GAAP earnings per share of 0.08 and the current share price of 69.33 USD. Check the full fundamental report for a full analysis of the valuation metrics for MLAB.
What is the Short Interest ratio of MESA LABORATORIES INC (MLAB) stock?
The outstanding short interest for MESA LABORATORIES INC (MLAB) is 5.97% of its float. Check the ownership tab for more information on the MLAB short interest.
MLAB Technical Analysis
MLAB Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to MLAB. While MLAB is still in line with the averages on profitability rating, there are concerns on its financial health.
MLAB Financial Highlights
Over the last trailing twelve months MLAB reported a non-GAAP Earnings per Share(EPS) of 0.08. The EPS decreased by -98.3% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.46% | ||
| ROE | -1.24% | ||
| Debt/Equity | 0.48 |
MLAB Forecast & Estimates
8 analysts have analysed MLAB and the average price target is 90.27 USD. This implies a price increase of 30.2% is expected in the next year compared to the current price of 69.33.
For the next year, analysts expect an EPS growth of 2600.57% and a revenue growth 3.51% for MLAB